Some startups walk in quiet. Others sync up, hit play, and drop the kind of beat that makes the room turn. Synthpop just raised a clean $15 million in an SEC-registered initial offering, and the healthcare automation game may never sleep again. This isn’t just another raise. It’s a signal that the operating table isn’t the only place in healthcare where precision matters.
Let’s talk brass tacks. Synthpop, founded in February 2023, isn’t trying to build buzzwords into the cloud. They’re building muscle into the system. Their AI-powered platform turns clunky, soul-sucking admin work into a background process that actually stays in the background. For the DME providers, diagnostic testing labs, and sleep clinics they serve, that’s not innovation, it’s air. Necessary. Inhale-worthy.
This round brings Synthpop’s total funding to $23.2 million. Peterson Ventures took the lead in their $5.6M seed last year, with defy.vc, Zelda Ventures, Think+ Ventures, and OVO Fund on the roster. The earlier $2.6M pre-seed had everyone from Newfund to AI Operators Fund and Flexcap in the mix. Names that don’t chase noise. They back real signal.
So why now? Because Synthpop’s engine is already humming. They’re deployed in 12 states. They’ve cut 20-minute processes down to 3. They’re automating up to 85% of administrative sludge. Faxed forms, insurance verifications, phone calls, processed, audited, validated, and actioned in less time than it takes most clinics to brew a pot of burnt coffee.
Big shout to CEO Elad Ferber, who co-founded Spry Health (acquired by Itamar Medical, NASDAQ: ITMR), and CTO Jan Jannink, a Stanford PhD and former CTO at VoiceBase and imeem. These aren’t LinkedIn bio builders. These are technologists who’ve touched real pain, and are back to treat it at scale.
The tools? A stack of HIPAA-compliant AI that actually deserves the acronym. From Document Wrangler to Order Validator to a beta-stage voice assistant called Conversational AI, every module in the Synthpop orchestra hits its note. There’s even a patent pending for anonymizing healthcare data for machine learning, because when your customers run on trust, privacy isn’t a feature, it’s a prerequisite.
Add in Director of Clinical Ops Dr. Drew Copeland (ex-Mount Sinai) and VP of Sales Chip Smith (ResMed, AdaptHealth), and you’ve got a team that knows the terrain. They’re not trying to learn the market; they’ve built in it, scaled in it, and now they’re automating it.
The next move? 20+ hires, national expansion, and full deployment of their voice AI. Synthpop isn’t trying to be part of the future of healthcare ops. They’re engineering it.
